Vaz Sara Nunes, Giovanetti Marta, Rego Filipe Ferreira de Almeida, Oliveira Tulio de, Danaviah Siva, Gonçalves Maria Luiza Freire, Alcantara Luiz Carlos Junior, Brites Carlos
1 Retrovirology Laboratory, Federal University of Bahia , Salvador, Bahia, Brazil .
2 Laboratory of Hematology, Genetics and Computational Biology, Gonçalo Moniz Research Center , Oswaldo Cruz Foundation, Salvador, Bahia, Brazil .
AIDS Res Hum Retroviruses. 2015 Oct;31(10):1046-51. doi: 10.1089/AID.2015.0166.
Approximately 35 million people worldwide are infected with human immunodeficiency virus (HIV) around 3.2 million of whom are children under 15 years. Mother-to-child-transmission (MTCT) of HIV-1 accounts for 90% of all infections in children. Despite great advances in the prevention of MTCT in Brazil, children are still becoming infected. Samples from 19 HIV-1-infected families were collected. DNA was extracted and fragments from gag, pol, and env were amplified and sequenced directly. Phylogenetic reconstruction was performed. Drug resistance analyses were performed in pol and env sequences. We found 82.1% of subtype B and 17.9% of BF recombinants. A prevalence of 43.9% drug resistance-associated mutations in pol sequences was identified. Of the drug-naive children 33.3% presented at least one mutation related to protease inhibitor/nucleoside reverse transcriptase inhibitor/nonnucleoside reverse transcriptase inhibitor (PI/NRTI/NNRTI) resistance. The prevalence of transmitted drug resistance mutations was 4.9%. On env we found a low prevalence of HR1 (4.9%) and HR2 (14.6%) mutations.
全球约有3500万人感染了人类免疫缺陷病毒(HIV),其中约320万是15岁以下的儿童。HIV-1的母婴传播(MTCT)占儿童所有感染的90%。尽管巴西在预防MTCT方面取得了巨大进展,但仍有儿童感染。收集了19个HIV-1感染家庭的样本。提取DNA并直接扩增和测序gag、pol和env的片段。进行了系统发育重建。对pol和env序列进行了耐药性分析。我们发现82.1%为B亚型,17.9%为BF重组体。在pol序列中鉴定出43.9%的耐药相关突变。在未接受过药物治疗的儿童中,33.3%至少有一个与蛋白酶抑制剂/核苷类逆转录酶抑制剂/非核苷类逆转录酶抑制剂(PI/NRTI/NNRTI)耐药相关的突变。传播耐药突变的发生率为4.9%。在env上,我们发现HR1(4.9%)和HR2(14.6%)突变的发生率较低。